Women, power, and cancer: a Lancet Commission

O Ginsburg, V Vanderpuye, AM Beddoe, N Bhoo-Pathy… - The Lancet, 2023 - thelancet.com
Executive summary Women interact with cancer in complex ways, as healthy individuals
participating in cancer prevention and screening activities, as individuals living with and …

Male breast cancer

IS Fentiman, A Fourquet, GN Hortobagyi - The Lancet, 2006 - thelancet.com
Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases
usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high …

The global burden of women's cancers: a grand challenge in global health

O Ginsburg, F Bray, MP Coleman, V Vanderpuye… - The Lancet, 2017 - thelancet.com
Every year, more than 2 million women worldwide are diagnosed with breast or cervical
cancer, yet where a woman lives, her socioeconomic status, and agency largely determines …

Women in science, medicine, and global health: call for papers

J Clark, E Zuccala, R Horton - The Lancet, 2017 - thelancet.com
Our focus is on looking forwards. We are not interested in descriptive pieces that cover
known ground or describe the problem, but instead papers that extend understandings and …

Changing global policy to deliver safe, equitable, and affordable care for women's cancers

O Ginsburg, R Badwe, P Boyle, G Derricks, A Dare… - The Lancet, 2017 - thelancet.com
Breast and cervical cancer are major threats to the health of women globally, particularly in
low-income and middle-income countries. Radical progress to close the global cancer …

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

B Thewes, B Meiser, VM Duric, MR Stockler… - The Lancet …, 2005 - thelancet.com
Background Adjuvant endocrine therapies such as tamoxifen, goserelin, and oophorectomy
improve survival for premenopausal women diagnosed with early-stage breast cancer …

Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer

F Eisinger, G Geller, W Burke, NA Holtzman - The Lancet, 1999 - thelancet.com
920 THE LANCET• Vol 353• March 13, 1999 as well. 5 The US Congress has only recently
required health plans to pay for breast reconstruction, 6 whereas reconstruction has been …

15 million new cancer cases per year by 2020, says WHO

H Frankish - The Lancet, 2003 - thelancet.com
Cancer rates worldwide are expected to soar by 50% over the next 20 years, according to
the World Cancer Report published by WHO on April 3, unless action is taken to tackle …

Lesbians and cancer: an overlooked health disparity

JP Brown, JK Tracy - Cancer Causes & Control, 2008 - Springer
Objective To evaluate the breast, cervical, ovarian, lung, and colorectal cancer literatures
using a novel application of the cancer disparities grid to identify disparities along domains …

Menarche, menopause, and breast cancer risk

K Britt - The lancet oncology, 2012 - thelancet.com
The longer a woman is exposed to cycling reproductive hormones the higher her risk of
breast cancer. If she has an early menarche or a late menopause, or both, her risk of breast …